摘要
目的 观察疏肝养血润目针灸法治疗水样液缺乏性干眼(ATD)的临床疗效及安全性。方法 纳入2021年6月—2023年6月唐山市丰润区人民医院诊治的ATD肝肾阴虚证患者98例(196只眼),采用随机数字表法分成对照组和治疗组,最终每组纳入48例(96只眼)。对照组予1.4%聚乙烯醇滴眼液治疗,治疗组在对照组基础上联合疏肝养血润目针灸法。2组均观察4周。分别于治疗前、后检测受试者的泪膜破裂时间(BUT)、泪液分泌试验(SⅠT)、角膜荧光染色(FL)、白细胞介素(IL)-1β、IL-6、金属基质蛋白酶-9(MMP-9)水平及中医证候积分。结果 (1)BUT:治疗前后比较,2组治疗后BUT均较治疗前延长,差异均有统计学意义(t_(治疗组)=50.217、t_(对照组)=40.909,均P=0.000)。治疗组治疗后BUT长于对照组,差异有统计学意义(t=7.349,P=0.000)。(2)SⅠT:治疗前后比较,2组治疗后SⅠT均较治疗前延长,差异均有统计学意义(t_(治疗组)=46.149、t_(对照组)=42.726,均P=0.000)。治疗组治疗后SⅠT长于对照组,差异有统计学意义(t=7.078,P=0.000)。(3)FL:治疗前后比较,2组治疗后FL均较治疗前降低,差异均有统计学意义(t_(治疗组)=50.398、t_(对照组)=42.955,均P=0.000)。治疗组治疗后FL低于对照组,差异有统计学意义(t=8.688,P=0.000)。(4)泪液炎症因子:治疗前后比较,2组治疗后IL-1β、IL-6及MMP-9水平均较治疗前降低,差异均有统计学意义(IL-1β:t_(治疗组)=71.214、t_(对照组)=51.982,均P=0.000;IL-6:t_(治疗组)=83.398、t_(对照组)=70.133,均P=0.000;MMP-9:t_(治疗组)=673.908、t_(对照组)=623.730,均P=0.000)。治疗组治疗后IL-1β、IL-6及MMP-9均低于对照组,差异均有统计学意义(t_(IL-1β)=10.708、t_(IL-6)=9.689、t_(MMP-9)=9.155,均P=0.000)。(5)中医证候积分:治疗前后比较,2组治疗后中医证候积分均较治疗前降低,差异均有统计学意义(t_(治疗组)=54.729、t_(对照组)=46.822,均P=0.000)。治疗组治疗后中医证候积分低于对照组,差异有统计学意义(t=11.622,P=0.000)。(6)临床疗效:治疗组总有效率为92.71%,高于对照组的82.29%,差异有统计学意义(χ~2=4.762,P=0.029)。(7)不良反应:2组不良反应比较,差异无统计学意义(P>0.05)。结论 对ATD患者实施疏肝养血润目针灸法联合人工泪液治疗,可有效缓解症状,明显改善FL等泪膜稳定性指标,且安全性高。
OBJECTIVE To observe the clinical efficacy and safety of Shugan Yangxue Runmu acupuncture method in treating aqueous deficient dry eye(ATD).METHODS A total of 98 ATD patients(196 eyes)treated at Tangshan Fengrun People's Hospital from June 2021 to June 2023 were included.They were randomly divided into a control group(CG)and a treatment group(TG)using a random number table,with 48 patients(96 eyes)in each group.The control group received 1.4%polyvinyl alcohol eye drops,while the treatment group received Shugan Yangxue Runmu acupuncture method in addition to the control group treatment.Both groups were observed for four weeks.The tear film break-up time(BUT),SchirmerⅠtest(SⅠT),corneal fluorescein staining(FL),the level of interleukin(IL)-1β,IL-6 and matrix metalloproteinase-9(MMP-9),and Traditional Chinese Medicine(TCM)symptom scores were measured before and after treatment.RESULTS(1)BUT:After treatment,BUT in both groups was significantly longer than before treatment(t_(TG)=50.217,t_(CG)=40.909,both P=0.000).The treatment group's BUT was longer than the control group's after treatment,with a statistically significant difference(t=7.349,P=0.000).(2)SⅠT:After treatment,SⅠT in both groups was significantly longer than before treatment(t_(TG)=46.149,t_(CG)=42.726,both P=0.000).The treatment group's SⅠT was longer than the control group's after treatment,with a statistically significant difference(t=7.078,P=0.000).(3)FL:After treatment,FL in both groups was significantly lower than before treatment(t_(TG)=50.398,t_(CG)=42.955,both P=0.000).The treatment group's FL was lower than the control group's after treatment,with a statistically significant difference(t=8.688,P=0.000).(4)Tear inflammatory factors:After treatment,IL-1β,IL-6,and MMP-9 levels in both groups were significantly lower than before treatment(IL-1β:t_(TG)=71.214,t_(CG)=51.982,both P=0.000;IL-6:t_(TG)=83.398,t_(CG)=70.133,both P=0.000;MMP-9:t_(TG)=673.908,t_(CG)=623.730,both P=0.000).The treatment group's IL-1β,IL-6,and MMP-9 levels were lower than the control group's after treatment,with statistically significant differences(tIL-1β=10.708,tIL-6=9.689,tMMP-9=9.155,all P=0.000).(5)TCM syndrome scores:After treatment,TCM symptom scores in both groups were significantly lower than those before treatment(t_(TG)=54.729,t_(CG)=46.822,both P=0.000).The treatment group's TCM symptom scores were lower than those in the control group's after treatment,with a statistically significant difference(t=11.622,P=0.000).(6)Clinical efficacy:The overall effective rate was 92.71%in the treatment group,higher than 82.29%in the control group,with a statistically significant difference(χ2=4.762,P=0.029).(7)Adverse effects:There was no statistically significant difference in adverse reactions between the two groups(P>0.05).CONCLUSIONS For ATD patients,Shugan Yangxue Runmu acupuncture method combined with artificial tears can effectively alleviate symptoms,significantly improve tear film stability indicators such as FL,and has high safety.
作者
于爱忠
张敬敬
葛顺成
安致稳
阴雅男
YU Aizhong;ZHANG Jingjing;GE Shuncheng;AN Zhi-wen;YIN Yanan(Tangshan Fengrun People's Hospital,Tangshan 064099,China)
出处
《中国中医眼科杂志》
2024年第9期840-845,共6页
China Journal of Chinese Ophthalmology
基金
河北省中医药管理局科研计划项目(2021390)。
关键词
疏肝养血润目
针灸
人工泪液
水样液缺乏性干眼
Shugan Yangxue Runmu
acupuncture
artificial tears
aqueous deficient dry eye